PI Name PI Organization Title Grant Number Initiative Program Director
Eibl, Guido Erwin Michael

University Of California Los Angeles
United States

Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma 5P01CA236585-03 PAR-18-290 (P01 Clinical Trial Optional) Sharon Ross, Ph.D., M.P.H.
Agarwal, Rajesh

University Of Colorado Denver
United States

Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy 3R01CA140368-10S1 PA-20-227 (Admin Supp-Clinical Trial Not Allowed) Amit Kumar, Ph.D.
Xing, Chengguo

University Of Florida
United States

Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation 1R03CA273467-01 Gabriela Riscuta, M.D., C.N.S.
Webster, Nicholas J

University Of California, San Diego
United States

Time-restricted feeding and breast cancer 2R01CA196853-06A1 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Welsh, Joellen

State University Of New York At Albany
United States

Vitamin K: Body Pools and Function in Breast Cancer 3R01CA258231-03S1 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Sharon Ross, Ph.D., M.P.H.
Stolley, Melinda R

Medical College Of Wisconsin
United States

Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors 3R01CA229546-05S1 Sharon Ross, Ph.D., M.P.H.
Shinde, Rahul Suresh

Wistar Institute
United States

The role of gut microbe-derived choline metabolites in driving the pro-inflammatory macrophage phenotype and restricting pancreatic cancer 5R21CA259240-02 PAR-19-199 (R21 Clinical Trial Not Allowed) Gabriela Riscuta, M.D., C.N.S.
Yun, Jihye

Baylor College Of Medicine
United States

Impact of sugary drinks on gut microbiota and development of young-onset colorectal cancer 1R21CA258134-01 RFA-CA-20-005 (R21 Clinical Trial Optional) Gabriela Riscuta, M.D., C.N.S.
Marchand, Loic Le

University Of Hawaii At Manoa
United States

Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial 5R01CA258179-02 RFA-CA-20-004 (R01 Clinical Trial Optional) Gabriela Riscuta, M.D., C.N.S.
Kong, Ah-Ng Tony

Rutgers, The State Univ Of N.J.
United States

Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics 5R01CA200129-05 Sharon Ross, Ph.D., M.P.H.